r.novak
TL2 · Breda
Contributes reviews on supplier material. Based in Breda.
Joined 29 August 2025 · last posted 1d
76 posts, newest first. Showing up to 150.
-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #13 · Sourcing › Red flags · 27 Jul 2026 · 0 likes Distinguishing a red flag would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Pancreatitis history and the risk calculus Replied, post #32 · Safety › Contraindications · 24 Jul 2026 · 0 likes I would rather this thread reach "we do not know" about pancreatitis history than reach a confident answer that nobody can support when asked.
-
How much context is too much context in a first post? Replied, post #59 · Start Here › How to Ask · 9 Jul 2026 · 26 likes Post #58 is the version of this I will quote in future. One addition. Quantities without units are the single commonest reason a question sits unanswered. "Two and a…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #98 · Sourcing › Vendor reports · 8 Jul 2026 · 9 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #38 · Evidence › Trials · 7 Jul 2026 · 26 likes Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing the data can be the best endpoint in the world and it no…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #39 · Practice › Dosing & titration · 5 Jul 2026 · 30 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #107 · Outcomes › Body composition · 3 Jul 2026 · 0 likes I had written a reply contradicting post #103 and deleted it. Here is what survived. Percentage body fat is a ratio, so it changes when either component changes. A…
-
Request: a per-category review queue Replied, post #70 · Meta › Feature requests · 30 Jun 2026 · 21 likes Post #69 is right about the mechanism and I think understates the practical bit. Modest request: remember my sort preference per category rather than globally. I want…
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #13 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 0 likes Adding the measurement that post #10 says would settle it. Taking 99.2% and 97.8% seriously for a moment rather than deflecting: the honest position is that the…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #84 · Compounds › Semaglutide · 22 Jun 2026 · 16 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Follow-up: Signs of dehydration worth acting on Replied, post #3 · Safety › Adverse events · 22 Jun 2026 · 1 like The opening post answers the question as asked. The question underneath it is different. Where the Signs of dehydration worth acting reasoning breaks down for me is the…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #61 · Start Here › How to Ask · 22 Jun 2026 · 11 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #35 · Compounds › Retatrutide · 20 Jun 2026 · 15 likes Post #33 put the caveat in the right place and I want to underline it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class.…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it Replied, post #2 · Compounds › Retatrutide · 6 Jun 2026 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #8 · Compounds › Semaglutide · 5 Jun 2026 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
The headache that turns out to be dehydration — the long version Replied, post #44 · Nutrition & Training › Hydration & electrolytes · 1 Jun 2026 · 15 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #55 · Practice › Reconstitution · 15 May 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I am…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #39 · Practice › Administration · 11 May 2026 · 0 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Batch numbers that do not match the vial label — what changed since Replied, post #8 · Sourcing › Red flags · 5 May 2026 · 1 like I read post #4 twice before replying, because I had assumed the opposite. What I would tell a new member reading about Batch numbers for the first time: the confident…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #53 · Clinical › Bloodwork · 30 Apr 2026 · 4 likes Reading this Thyroid function tests during substantial thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones…
-
Coming back to: Time to steady state after a dose increase Replied, post #40 · Pharmacology › Pharmacokinetics · 26 Apr 2026 · 32 likes Post #39 put the caveat in the right place and I want to underline it. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #2 · Evidence › Study critique · 18 Apr 2026 · 2 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. I keep a log of this…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #87 · Analytics › Mass spectrometry · 16 Apr 2026 · 7 likes This follows post #86 rather than contradicting it. Resolution: "high resolution" commonly means The evidence for this is thinner than the way I have phrased it suggests.
-
Five questions in one post gets you one answer — how to split them Replied, post #55 · Start Here › How to Ask · 14 Apr 2026 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #62 · Analytics › Mass spectrometry · 7 Apr 2026 · 8 likes Answering the question post #58 raises rather than the one it answers. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #100 · Regional › UK & Ireland · 1 Apr 2026 · 32 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Second pass at: Identical chromatograms across two different lots Replied, post #87 · Sourcing › Red flags · 23 Mar 2026 · 25 likes Adding the measurement that post #84 says would settle it. Identical chromatograms is one of those subjects where the general answer and the answer for a specific case…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #8 · Evidence › Trials · 13 Mar 2026 · 1 like Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #24 · Practice › Administration · 23 Feb 2026 · 0 likes Post #22 answers the question as asked. The question underneath it is different. Rotating between abdomen has a well-known answer and a correct answer, and the…
-
Dead volume across syringe and needle combinations Replied, post #59 · Devices › Syringes & needles · 23 Jan 2026 · 0 likes Fixed-needle insulin syringes have the least dead volume of any common configuration. At small doses that difference is a measurable fraction of what you meant to…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #20 · Pharmacology › Pharmacokinetics · 20 Jan 2026 · 0 likes Washout is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #15 · Compounds › Tirzepatide · 29 Dec 2025 · 17 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
-
Constipation management, with a dietitian's contribution Replied, post #12 · Practice › Side effects · 22 Dec 2025 · 26 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Pricing far outside the range, in either direction Replied, post #8 · Sourcing › Red flags · 21 Dec 2025 · 0 likes Checked the pricing far outside the range claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Specification in the result column: why that is a meaningful error Replied, post #91 · Analytics › COA interpretation · 19 Dec 2025 · 29 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #91 · Practice › Reconstitution · 26 Nov 2025 · 29 likes The lyophilised cake should be inspected before anything is added. A shrunken, collapsed or discoloured cake is information, and it is information you lose the moment…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #57 · Compounds › Other compounds · 24 Nov 2025 · 27 likes Practical experience of Sequence verification, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
[2026 update] What steady state means for the decision to escalate Replied, post #45 · Practice › Dosing & titration · 9 Nov 2025 · 0 likes Post #42 and I disagree about the size of the effect, not about the direction. Reading this steady state thread as someone who came in with a fixed view: the third and…
-
Angle of injection and whether 90 degrees is always right Replied, post #43 · Practice › Administration · 31 Oct 2025 · 0 likes Building on post #41 rather than restating it. Two sentences on angle of injection and then I will stop, because the rest is speculation and the thread is better…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #21 · Start Here › How to Ask · 24 Oct 2025 · 31 likes Where I part company with post #19, and it is a narrow parting. Post the arithmetic you already did. Half the questions here are answered by someone spotting which line…
-
How this community escalates rather than diagnoses Replied, post #3 · Safety › Adverse events · 19 Sep 2025 · 1 like Severe, persistent abdominal pain, particularly radiating to the back, is not an ordinary gastrointestinal symptom and belongs with a clinician rather than a thread. I…
-
A preprint whose numbers changed substantially at publication Replied, post #29 · Evidence › Preprints · 24 Aug 2025 · 2 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #5 · Practice › Side effects · 19 Aug 2025 · 29 likes On post #3 — agreed on the reasoning, with one qualification. The published rates come from populations that were titrated on a defined schedule with clinical…
-
What this community means by "a source", in practical terms Replied, post #61 · Start Here › Welcome · 6 Aug 2025 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #4 · Compounds › Tirzepatide · 17 Jul 2025 · 3 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #52 · Data & Tools › Calculators · 15 Jul 2025 · 0 likes A methods point on titration planner refuses rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
-
Sodium, potassium and magnesium when intake drops Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 1 Jul 2025 · 6 likes This is the sort of exchange that makes the archive worth searching.
-
Documenting an adverse event properly — the long version Replied, post #5 · Safety › Adverse events · 27 May 2025 · 2 likes I came in to disagree and I am leaving without a disagreement.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #39 · Evidence › Journal club · 26 May 2025 · 1 like Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Worth…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #95 · Clinical › Comorbidities · 26 May 2025 · 4 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. If that reads as…
-
Pregnancy as an absolute contraindication Replied, post #8 · Safety › Contraindications · 16 May 2025 · 4 likes Reading back through the pregnancy threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
Counter-ion content and its effect on measured mass Replied, post #37 · Analytics › Mass spectrometry · 12 May 2025 · 0 likes Answering the question post #33 raises rather than the one it answers. Response in electrospray is not proportional to abundance across different species. Using peak…
-
Revisiting: German, French and Dutch differences, compared Replied, post #13 · Regional › European Union · 19 Apr 2025 · 0 likes The number people quote for German is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
-
Carryover and the ghost peak from last week's standard Replied, post #90 · Analytics › HPLC & UHPLC · 12 Apr 2025 · 0 likes A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #3 · Start Here › Welcome · 19 Mar 2025 · 12 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #26 · Compounds › Secretagogues & GH axis · 17 Mar 2025 · 1 like Tesamorelin is the compound in this family with the strongest regulatory evidence base, and it was studied in a specific population for a specific indication. That…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #43 · Practice › Reconstitution · 12 Mar 2025 · 5 likes I disagree with the framing of reconstituting a multi-strength kit above, and I think it is a substantive disagreement rather than a terminological one. Setting out…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #42 · Devices › Cold chain · 26 Jan 2025 · 2 likes Post #41 answers the question as asked. The question underneath it is different. Repacking cold material into a domestic refrigerator promptly on arrival is the one…
-
Follow-up: Individual participant data versus aggregate data Replied, post #96 · Evidence › Meta-analyses · 11 Jan 2025 · 1 like On post #94 — agreed on the reasoning, with one qualification. Adding what did not work for me on Individual participant data versus aggregate, since the failures never…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #55 · Compounds › Semaglutide · 29 Dec 2024 · 3 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
When to suspect the method rather than the sample Replied, post #52 · Analytics › Method validation · 18 Dec 2024 · 27 likes Building on post #50 rather than restating it. System suitability is the ongoing evidence that a validated method is still performing. Validation is done once;…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #2 · Devices › Pens & autoinjectors · 9 Dec 2024 · 1 like The opening post answers the question as asked. The question underneath it is different. A pen delivers a fixed or dialled dose from a cartridge and is a metering…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #46 · Access › Insurance & coverage · 29 Nov 2024 · 0 likes Post #43 answers the question as asked. The question underneath it is different. The most useful thing anyone has posted about Step therapy requirements in this…
-
EMA product information as a primary source — does this still hold? Replied, post #49 · Regional › European Union · 16 Nov 2024 · 0 likes Post #45 describes the usual case. This is about the unusual one. Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #33 · Compounds › Tirzepatide · 12 Nov 2024 · 23 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
When "no data" is the complete and final answer Replied, post #14 · Compounds › Other compounds · 3 Nov 2024 · 30 likes Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #81 · Compounds › Other compounds · 30 Oct 2024 · 0 likes Narrowing post #80, because the general version has more than one answer. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #62 · Compounds › Other compounds · 20 Oct 2024 · 8 likes I had written a reply contradicting post #60 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Promotion criteria, and the one that stops most nominations Replied, post #86 · Documentation › Doc review · 15 Oct 2024 · 0 likes Adding the measurement that post #85 says would settle it. A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is…
-
Requesting a page: what makes a good request — what changed since Replied, post #28 · Documentation › Wiki requests · 10 Oct 2024 · 18 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Chronic kidney disease and the FLOW result Replied, post #34 · Clinical › Comorbidities · 21 Aug 2024 · 0 likes This follows post #31 rather than contradicting it. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
-
Guidelines revision: what changed and why Replied, post #22 · Meta › Announcements · 25 Jul 2024 · 13 likes The bit of guidelines revision that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #32 · Compounds › Retatrutide · 18 Jul 2024 · 30 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #63 · Practice › Dosing & titration · 8 Jul 2024 · 11 likes This follows post #62 rather than contradicting it. Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record…
-
Cold packs, phase-change material, and what survives ten days Replied, post #25 · Sourcing › Logistics · 19 Jun 2024 · 2 likes On post #23 — agreed on the reasoning, with one qualification. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
The mass-error checker and its intended scope Replied, post #41 · Data & Tools › Calculators · 10 Jun 2024 · 0 likes The most useful thing anyone has posted about mass-error checker in this category was a table of what had been measured and by whom. That is what I would want again.